Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v10-EN | Version v3-FR | |
|---|---|---|
| Language | English | French |
| Date Updated | 2023-10-26 | 2023-10-16 |
| Drug Identification Number | 02382857 | 02382857 |
| Brand name | GLYCOPYRROLATE INJECTION | GLYCOPYRROLATE INJECTION |
| Common or Proper name | Glycopyrrolate Injection | Glycopyrrolate Injection |
| Company Name | OMEGA LABORATORIES LIMITED | OMEGA LABORATORIES LIMITED |
| Ingredients | GLYCOPYRROLATE | GLYCOPYRROLATE |
| Strength(s) | 0.2MG | 0.2MG |
| Dosage form(s) | LIQUID | LIQUID |
| Route of administration | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR | INTRAVENOUS INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR |
| Packaging size | 10 x 1mL vial / fiole | 10 x 1mL vial / fiole |
| ATC code | A03AB | A03AB |
| ATC description | DRUGS FOR FUNCTIONAL BOWEL DISORDERS | DRUGS FOR FUNCTIONAL BOWEL DISORDERS |
| Reason for shortage | Demand increase for the drug. | Demand increase for the drug. |
| Anticipated start date | 2023-10-26 | |
| Actual start date | 2023-10-23 | |
| Estimated end date | 2023-11-03 | 2023-10-31 |
| Actual end date | 2023-10-25 | |
| Shortage status | Resolved | Anticipated shortage |
| Tier 3 Status | No | No |
| Company comments | Product available at CPDN. 2 mL format available as substitute. | |
| Health Canada comments |